BioCryst Pharmaceuticals is a drug manufacturers - specialty & generic business based in the US. BioCryst Pharmaceuticals shares (BCRX) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $6.76 – an increase of 5.96% over the previous week. BioCryst Pharmaceuticals employs 580 staff and has a trailing 12-month revenue of around $599.8 million.
Become a Finder member, open a SoFi Active Invest account and make a first deposit of $1,000 or more to receive a $150 gift card. Offer ends March 4, 2026.
T&Cs and limits apply.
0588148b-2286-4b8f-9672-9c8cdafc0370-Get up to $1,000 in stock
Get up to $1,000 in stock
Trade stocks, options, ETFs, mutual funds, alternative asset funds
$0 commission on stocks, ETFs and options with no options contract fees
Get up to $1,000 in stock when you open & fund a new Active Invest account.
Probability of Member receiving $1,000 is a probability of 0.026%; If you don’t make a selection in 45 days, you’ll no longerqualify for the promo. Customer must fund their account with a minimum of $50.00 to qualify. Probability percentage is subject to decrease.
Terms and conditions apply*. For 401k rollovers, existing SoFi IRA members must complete 401k rollovers via this link See full terms and For SoFi members without a SoFi IRA, a SoFi IRA must first be opened, and 401k rollover must be completed utilizing Capitalize via this link. SoFi and Capitalize will charge no additional fees to process a 401(k) rollover to a SoFi IRA. SoFi is not liable for any costs incurred from the existing 401k provider for rollover. Please check with your 401k provider for any fees or costs associated with the rollover. For IRA contributions, only deposits made via ACH and cash transfer from SoFi Bank accounts are eligible for the match. Click here for the 1% Match terms and conditions.
Must be a SoFi Plus member at the time a recurring deposit is received into your SoFi Active or Automated investing account to qualify. Bonus calculated on net monthly recurring deposits made via ACH and paid out as Rewards Points. See Rewards Terms of Service. SoFi reserves the right to change or terminate this promotion at any time without notice. See terms and limitations. https://www.sofi.com/sofiplus/invest/#disclaimers
eToro securities trading offered by eToro USA Securities, Inc. (‘the BD”), member of FINRA and SIPC. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. Finder is not an affiliate and may be compensated if you access certain products or services offered by the BD.
d19c0be9-29b6-4644-a071-32c476ff5e24-Top pick for match bonus
Top pick for match bonus
Trade stocks, ETFs, options, futures and bonds all in one place
$0 commissions on stocks, ETFs and equity options, with low contract fees
Deposit or transfer $100,000+ to earn a 4% Match Bonus. Plus: Get a $100 transfer fee reimbursement on your first brokerage transfer of $2,000 or more. T&C apply.
Open an account.Provide your personal information and sign up.
Fund your account.Deposit funds into your account by linking your banking information or transfer funds from another trading account.
Search for the stock name – BCRX.Search for the stock by name or ticker symbol.
Buy the stock. Place your order. It's that simple.
Buy BioCryst Pharmaceuticals stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Is it a good time to buy BioCryst Pharmaceuticals stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
BioCryst Pharmaceuticals price performance over time
Historical closes compared with the close of $6.8 from 2026-02-12
1 week (2026-02-06)
6.58%
1 month (2026-01-14)
0.29%
3 months (2025-11-14)
-3.95%
6 months (2025-08-14)
-19.53%
1 year (2025-02-14)
-24.86%
2 years (2024-02-14)
22.08%
3 years (2023-02-14)
10.34
5 years (2021-02-12)
9.57
Is BioCryst Pharmaceuticals stock undervalued or overvalued?
Valuing BioCryst Pharmaceuticals stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of BioCryst Pharmaceuticals's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
BioCryst Pharmaceuticals's EBITDA
BioCryst Pharmaceuticals's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $80.4 million.
The EBITDA is a measure of a BioCryst Pharmaceuticals's overall financial performance and is widely used to measure a its profitability.
BioCryst Pharmaceuticals financials
Revenue TTM
$599.8 million
Operating margin TTM
18.57%
Gross profit TTM
$410.5 million
Return on assets TTM
10.31%
Return on equity TTM
-1925.37%
Profit margin
-1.46%
Book value
$-1.84
Market Capitalization
$1.6 billion
TTM: trailing 12 months
BioCryst Pharmaceuticals share dividends
We're not expecting BioCryst Pharmaceuticals to pay a dividend over the next 12 months.
BioCryst Pharmaceuticals share price volatility
Over the last 12 months, BioCryst Pharmaceuticals's shares have ranged in value from as little as $6 up to $11.31. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while BioCryst Pharmaceuticals's is 0.793. This would suggest that BioCryst Pharmaceuticals's shares are less volatile than average (for this exchange).
BioCryst Pharmaceuticals overview
BioCryst Pharmaceuticals, Inc. , a biotechnology company, develops oral small-molecule and injectable protein therapeutics to treat rare diseases. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat hereditary angioedema. It is also developing BCX17725, a protein therapeutic for netherton syndrome which is in phase 1; Avoralstat, an ocular plasma kallikrein inhibitor for diabetic macular edema that is in preclinical phase; and BCX10013, an oral Factor D inhibitor for complement-mediated diseases, as well as developing Oral C5 Inhibitor and Oral C2 Inhibitor. It also engages in the discovery, development, and commercialization of therapeutics for allergic and immunological diseases. The company has collaborations and in-license relationships with the Torii Pharmaceutical Co. , Shionogi & Co.
Frequently asked questions
null What percentage of BioCryst Pharmaceuticals is owned by insiders or institutions? Currently 1.324% of BioCryst Pharmaceuticals shares are held by insiders and 85.157% by institutions.How many people work for BioCryst Pharmaceuticals? Latest data suggests 580 work at BioCryst Pharmaceuticals.When does the fiscal year end for BioCryst Pharmaceuticals? BioCryst Pharmaceuticals's fiscal year ends in December.Where is BioCryst Pharmaceuticals based? BioCryst Pharmaceuticals's address is: 4505 Emperor Boulevard, Durham, NC, United States, 27703What is BioCryst Pharmaceuticals's ISIN number? BioCryst Pharmaceuticals's international securities identification number is: US09058V1035What is BioCryst Pharmaceuticals's CUSIP number? BioCryst Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 09058V103
Discover the best stock picking services based on expert analysis, pricing, and strategy fit. Compare top tools to find the right service for your investing style in 2026.
Discover the best robo-advisors of 2026. Compare fees, account minimums and features from top platforms that automate investing for beginners and pros.
Vanguard is an investor-owned company that specializes in low-cost funds, but some fees and features lag the competition.
Advertiser disclosure
Finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which Finder receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. Finder compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.
We update our data regularly, but information can change between updates. Confirm details with the provider you're interested in before making a decision.
How likely would you be to recommend Finder to a friend or colleague?
0
1
2
3
4
5
6
7
8
9
10
Very UnlikelyExtremely Likely
Required
Thank you for your feedback.
Our goal is to create the best possible product, and your thoughts, ideas and suggestions play a major role in helping us identify opportunities to improve.
